Title:
PHARMACEUTICAL COMBINATION COMPRISING GLUCOKINASE ACTIVATOR AND SGLT-2 INHIBITOR, COMPOSITION, COMBINATION PREPARATION, AND PREPARATION METHODS AND USES THEREOF
Document Type and Number:
Japanese Patent JP2022190165
Kind Code:
A
Abstract:
To provide a pharmaceutical combination comprising a glucokinase activator and an SGLT-2 inhibitor, a composition, a combination preparation, and preparation methods and uses thereof.SOLUTION: The present invention relates to a pharmaceutical combination, comprising a glucokinase activator or a pharmaceutically acceptable salt, isotopic label, crystal form, hydrate, solvate, diastereomer, or enantiomer thereof and an SGLT-2 inhibitor. The present invention further relates to a pharmaceutical composition, a fixed-dose combination preparation, and preparation methods and uses of the pharmaceutical composition and the fixed-dose combination preparation.SELECTED DRAWING: None
Inventors:
Chen power
Lee Young Guk
Wang Takamori
Gao Huisheng
Lee Young Guk
Wang Takamori
Gao Huisheng
Application Number:
JP2022178296A
Publication Date:
December 22, 2022
Filing Date:
November 07, 2022
Export Citation:
Assignee:
Hua Medicine (Shanghai) Ltd.
International Classes:
A61K31/4155; A61K9/20; A61K31/351; A61K47/12; A61K47/38; A61P3/00; A61P3/04; A61P3/10; A61P9/12; A61P13/12; A61P43/00
Attorney, Agent or Firm:
Patent Attorney Firm WisePlus